Aclaris Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
August 07, 2023 at 07:00 am EDT
Aclaris Therapeutics, Inc. reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported revenue was USD 1.87 million compared to USD 1.53 million a year ago. Net loss was USD 29.57 million compared to USD 20.53 million a year ago. Basic loss per share from continuing operations was USD 0.42 compared to USD 0.31 a year ago.
For the six months, revenue was USD 4.4 million compared to USD 2.98 million a year ago. Net loss was USD 57.73 million compared to USD 39.32 million a year ago. Basic loss per share from continuing operations was USD 0.84 compared to USD 0.62 a year ago.